人工智能在癌症诊断中的应用:改变医疗行业的游戏规则

IF 2.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Current pharmaceutical biotechnology Pub Date : 2024-06-06 DOI:10.2174/0113892010298852240528123911
Pramit Sahoo, Meghoparna Kundu, Jeenatara Begum
{"title":"人工智能在癌症诊断中的应用:改变医疗行业的游戏规则","authors":"Pramit Sahoo, Meghoparna Kundu, Jeenatara Begum","doi":"10.2174/0113892010298852240528123911","DOIUrl":null,"url":null,"abstract":"<p><p>Early cancer identification is essential for increasing survival rates and lowering the disease's burden in today's society. Artificial intelligence [AI]--based algorithms may help in the early detection of cancer and resolve problems with current diagnostic methods. This article gives an overview of the prospective uses of AI in early cancer detection. The authors go over the possible applications of Artificial Intelligence algorithms used for screening risk of malignancy in asymptomatic patients, investigating as well as prioritising symptomatic individuals, and more accurately diagnosing cancer recurrence. In screening programmes, the importance of patient selection and risk stratification is emphasised, and AI may be able to assist in identifying people who are most at risk of acquiring cancer. Aside from pathology slide and peripheral blood analysis, AI can also increase the diagnostic precision of imaging methods like computed tomography [CT] and mammography. A summary of various AI techniques is given in the review, covering more sophisticated deep learning and neural networks and more traditional models like logistic regression. The advantages of deep learning algorithms in spotting intricate patterns in huge datasets and their potential to increase the precision of cancer diagnosis are emphasised by the authors. The ethical concerns surrounding the application of AI in healthcare are also discussed, and include topics like prejudice, data security, and privacy. A review of the models now employed in clinical practice is included along with a discussion of the prospective clinical implications of AI algorithms. Examined are AI's drawbacks and hazards, such as resource requirements, data quality, and the necessity for consistent reporting. In conclusion, this study emphasises the utility of AI algorithms in the early detection of cancer and gives a general overview of the many strategies and difficulties involved in putting them into use in clinical settings.</p>","PeriodicalId":10881,"journal":{"name":"Current pharmaceutical biotechnology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Artificial Intelligence in Cancer Diagnosis: A Game-Changer in Healthcare.\",\"authors\":\"Pramit Sahoo, Meghoparna Kundu, Jeenatara Begum\",\"doi\":\"10.2174/0113892010298852240528123911\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Early cancer identification is essential for increasing survival rates and lowering the disease's burden in today's society. Artificial intelligence [AI]--based algorithms may help in the early detection of cancer and resolve problems with current diagnostic methods. This article gives an overview of the prospective uses of AI in early cancer detection. The authors go over the possible applications of Artificial Intelligence algorithms used for screening risk of malignancy in asymptomatic patients, investigating as well as prioritising symptomatic individuals, and more accurately diagnosing cancer recurrence. In screening programmes, the importance of patient selection and risk stratification is emphasised, and AI may be able to assist in identifying people who are most at risk of acquiring cancer. Aside from pathology slide and peripheral blood analysis, AI can also increase the diagnostic precision of imaging methods like computed tomography [CT] and mammography. A summary of various AI techniques is given in the review, covering more sophisticated deep learning and neural networks and more traditional models like logistic regression. The advantages of deep learning algorithms in spotting intricate patterns in huge datasets and their potential to increase the precision of cancer diagnosis are emphasised by the authors. The ethical concerns surrounding the application of AI in healthcare are also discussed, and include topics like prejudice, data security, and privacy. A review of the models now employed in clinical practice is included along with a discussion of the prospective clinical implications of AI algorithms. Examined are AI's drawbacks and hazards, such as resource requirements, data quality, and the necessity for consistent reporting. In conclusion, this study emphasises the utility of AI algorithms in the early detection of cancer and gives a general overview of the many strategies and difficulties involved in putting them into use in clinical settings.</p>\",\"PeriodicalId\":10881,\"journal\":{\"name\":\"Current pharmaceutical biotechnology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current pharmaceutical biotechnology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0113892010298852240528123911\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892010298852240528123911","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在当今社会,早期癌症识别对于提高生存率和降低疾病负担至关重要。基于人工智能(AI)的算法可能有助于癌症的早期检测,并解决目前诊断方法存在的问题。本文概述了人工智能在癌症早期检测中的应用前景。作者阐述了人工智能算法在筛查无症状患者的恶性肿瘤风险、调查有症状的人并确定其优先顺序以及更准确地诊断癌症复发等方面的可能应用。在筛查计划中,患者选择和风险分层的重要性得到了强调,而人工智能或许能帮助确定哪些人罹患癌症的风险最高。除了病理切片和外周血分析外,人工智能还能提高计算机断层扫描(CT)和乳腺放射摄影等成像方法的诊断精确度。综述中总结了各种人工智能技术,包括更复杂的深度学习和神经网络,以及逻辑回归等更传统的模型。作者强调了深度学习算法在发现庞大数据集中复杂模式方面的优势,以及它们在提高癌症诊断精确度方面的潜力。作者还讨论了围绕人工智能在医疗保健领域应用的伦理问题,包括偏见、数据安全和隐私等话题。作者回顾了目前临床实践中使用的模型,并讨论了人工智能算法的未来临床意义。研究还探讨了人工智能的缺点和危害,如资源需求、数据质量和报告一致性的必要性。总之,本研究强调了人工智能算法在癌症早期检测中的实用性,并概述了在临床环境中使用这些算法所涉及的许多策略和困难。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Artificial Intelligence in Cancer Diagnosis: A Game-Changer in Healthcare.

Early cancer identification is essential for increasing survival rates and lowering the disease's burden in today's society. Artificial intelligence [AI]--based algorithms may help in the early detection of cancer and resolve problems with current diagnostic methods. This article gives an overview of the prospective uses of AI in early cancer detection. The authors go over the possible applications of Artificial Intelligence algorithms used for screening risk of malignancy in asymptomatic patients, investigating as well as prioritising symptomatic individuals, and more accurately diagnosing cancer recurrence. In screening programmes, the importance of patient selection and risk stratification is emphasised, and AI may be able to assist in identifying people who are most at risk of acquiring cancer. Aside from pathology slide and peripheral blood analysis, AI can also increase the diagnostic precision of imaging methods like computed tomography [CT] and mammography. A summary of various AI techniques is given in the review, covering more sophisticated deep learning and neural networks and more traditional models like logistic regression. The advantages of deep learning algorithms in spotting intricate patterns in huge datasets and their potential to increase the precision of cancer diagnosis are emphasised by the authors. The ethical concerns surrounding the application of AI in healthcare are also discussed, and include topics like prejudice, data security, and privacy. A review of the models now employed in clinical practice is included along with a discussion of the prospective clinical implications of AI algorithms. Examined are AI's drawbacks and hazards, such as resource requirements, data quality, and the necessity for consistent reporting. In conclusion, this study emphasises the utility of AI algorithms in the early detection of cancer and gives a general overview of the many strategies and difficulties involved in putting them into use in clinical settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current pharmaceutical biotechnology
Current pharmaceutical biotechnology 医学-生化与分子生物学
CiteScore
5.60
自引率
3.60%
发文量
203
审稿时长
6 months
期刊介绍: Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
期刊最新文献
Dihydroartemisinin Modulates Prostate Cancer Progression by Regulating Multiple Genes via the Transcription Factor NR2F2. Extraction, Isolation, Characterization, and Development of Phospholipids Complex Nanocarrier for Improved Solubility, Antiasthmatic, and Pharmacokinetic Potential of Curcuminoids. A Liquid Band-Aid with Mesenchymal Stem Cell-Derived Exosomes for Wound Healing in Mice. Ampullaviruses: From Extreme Environments to Biotechnological Innovation. Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1